Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The number of cases of dengue are growing rapidly during the past few years. Major regions of the world that are affected by dengue are Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific. As per the numbers provided by WHO, the number of reported cases is continuously increasing.A rising prevalence of dengue virus has raised the demand for diagnostic kits, which is expected to drive the dengue testing market in the near future.
Presently, the diagnostic test kits that are available for testing dengue are less effective. Due to the unavailability of effective diagnostic tools and high price of existing test kits, a need has been created for cost effective test kits with high specificity and sensitivity. As a result, companies operating in the market are currently focusing on the development of cost-effective and reliable test methods for dengue testing. In addition, increasing research and development activities to develop highly specific and sensitive diagnostic kits is also expected to create new growth opportunities for the manufacturers of dengue test kits. The major focus of the manufacturers is to develop point-of-care tests, which are rapid, sensitive and easy to use. Presently, a large number of methods for the detection of dengue virus are still dependent on cell culture and mice inoculation and such type of methods are slow and costly. Hence, there is a strong need of developing rapid, easy to use and sensitive methods for detection of dengue.
Market Analysis and Insights: Global Dengue Testing Market
The global Dengue Testing market size is projected to reach US$ 236.3 million by 2026, from US$ 227.8 million in 2020, at a CAGR of 3.5%% during 2021-2026.
Global Dengue Testing Scope and Market Size
Dengue Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dengue Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Abnova
Roche Molecular Systems
Abbott Laboratories
InBios International
NovaTec Immundiagnostica
Sub.PerkinElmer
Quest Diagnostics
Certest Biotec
OriGene Technologies
Thermo Fisher
ELISA-Based Tests
RT-PCR Based Tests
Dengue IgG/IgM Rapid Test
Hospitals
Public Health Laboratory
Diagnostic Centers
Others
North America
Europe
China
Japan
Southeast Asia
India
Presently, the diagnostic test kits that are available for testing dengue are less effective. Due to the unavailability of effective diagnostic tools and high price of existing test kits, a need has been created for cost effective test kits with high specificity and sensitivity. As a result, companies operating in the market are currently focusing on the development of cost-effective and reliable test methods for dengue testing. In addition, increasing research and development activities to develop highly specific and sensitive diagnostic kits is also expected to create new growth opportunities for the manufacturers of dengue test kits. The major focus of the manufacturers is to develop point-of-care tests, which are rapid, sensitive and easy to use. Presently, a large number of methods for the detection of dengue virus are still dependent on cell culture and mice inoculation and such type of methods are slow and costly. Hence, there is a strong need of developing rapid, easy to use and sensitive methods for detection of dengue.
Market Analysis and Insights: Global Dengue Testing Market
The global Dengue Testing market size is projected to reach US$ 236.3 million by 2026, from US$ 227.8 million in 2020, at a CAGR of 3.5%% during 2021-2026.
Global Dengue Testing Scope and Market Size
Dengue Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dengue Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abnova
Roche Molecular Systems
Abbott Laboratories
InBios International
NovaTec Immundiagnostica
Sub.PerkinElmer
Quest Diagnostics
Certest Biotec
OriGene Technologies
Thermo Fisher
Market segment by Type, the product can be split into
ELISA-Based Tests
RT-PCR Based Tests
Dengue IgG/IgM Rapid Test
Market segment by Application, split into
Hospitals
Public Health Laboratory
Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
